New Drug Enhances Radiation Treatment for Brain Cancer in Preclinical Studies

Published May 15, 2013

New drug enhances radiation treatment for brain cancer in preclinical studies

Filed under: drug treatment programs in maryland

The scientists used an experimental drug, KU-60019, to block the activation of ATM, which led to the enhanced destruction of the gliomas due to their reduced ability to repair the DNA damage caused by the radiation treatment. … "Sadly, the average …
Read more on EurekAlert (press release)

Genentech's Obinutuzumab (GA101) Significantly Reduced the Risk of Disease …

Filed under: drug treatment programs in maryland

"People with CLL, particularly the elderly and those with additional medical problems, need new options," said Sandra Horning, M.D., global head, Clinical Development Hematology/Oncology. "As a former practicing hematologist, I believe GA101 has the …
Read more on Wall Street Journal (press release)

EntreMed Reports First Quarter 2013 Financial Results

Filed under: drug treatment programs in maryland

Download image. ROCKVILLE, Md., May 15, 2013 /PRNewswire/ — EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh …
Read more on PR Newswire (press release)